Manulife (Manufacturers Life Insurance)
RARE icon

Manulife (Manufacturers Life Insurance)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7M Sell
381,420
-69,699
-15% -$1.73M 0.01% 794
2026
Q1 		$9.45M Buy
451,119
+119,950
+36% +$2.7M 0.01% 872
2025
Q4 		$7.61M Sell
331,169
-13,754
-4% -$452K 0.01% 1013
2025
Q3 		$10.4M Sell
344,923
-45,466
-12% -$1.36M 0.01% 842
2025
Q2 		$14.2M Buy
390,389
+97,015
+33% +$3.5M 0.01% 706
2025
Q1 		$10.6M Buy
293,374
+76,787
+35% +$3.19M 0.01% 806
2024
Q4 		$9.11M Sell
216,587
-21,468
-9% -$1.07M 0.01% 938
2024
Q3 		$13.2M Sell
238,055
-9,083
-4% -$463K 0.01% 768
2024
Q2 		$10.2M Sell
247,138
-40,366
-14% -$1.72M 0.01% 835
2024
Q1 		$13.4M Buy
287,504
+15,165
+6% +$715K 0.01% 736
2023
Q4 		$13M Buy
272,339
+31,482
+13% +$1.22M 0.01% 753
2023
Q3 		$8.59M Sell
240,857
-2,071
-0.9% -$82.1K 0.01% 879
2023
Q2 		$11.2M Buy
242,928
+167,896
+224% +$7.79M 0.01% 758
2023
Q1 		$3.01M Sell
75,032
-9,188
-11% -$394K ﹤0.01% 1272
2022
Q4 		$3.81M Buy
84,220
+8,985
+12% +$353K ﹤0.01% 1187
2022
Q3 		$3.05M Sell
75,235
-10,955
-13% -$563K ﹤0.01% 1268
2022
Q2 		$5.19M Buy
86,190
+2,396
+3% +$147K ﹤0.01% 1083
2022
Q1 		$5.98M Buy
+83,794
New +$5.83M ﹤0.01% 1100
2021
Q2 		– Sell
-35,571
Closed -$4.05M – 3275
2021
Q1 		$4.05M Sell
35,571
-1,631
-4% -$222K ﹤0.01% 1344
2020
Q4 		$5.15M Buy
37,202
+4,071
+12% +$483K ﹤0.01% 1201
2020
Q3 		$2.72M Sell
33,131
-594
-2% -$49.2K ﹤0.01% 1335
2020
Q2 		$2.48M Sell
33,725
-962
-3% -$63.7K ﹤0.01% 1343
2020
Q1 		$1.54M Buy
34,687
+1,798
+5% +$93.4K ﹤0.01% 1386
2019
Q4 		$1.41M Sell
32,889
-963
-3% -$39.7K ﹤0.01% 1524
2019
Q3 		$1.44M Buy
33,852
+104
+0.3% +$5.65K ﹤0.01% 1479
2019
Q2 		$2.14M Sell
33,748
-374
-1% -$23.8K ﹤0.01% 1362
2019
Q1 		$2.37M Buy
34,122
+5,044
+17% +$288K ﹤0.01% 1383
2018
Q4 		$1.26M Sell
29,078
-1,344
-4% -$73.5K ﹤0.01% 1501
2018
Q3 		$2.32M Sell
30,422
-4,269
-12% -$347K ﹤0.01% 1425
2018
Q2 		$2.67M Buy
34,691
+1,444
+4% +$93.3K ﹤0.01% 1410
2018
Q1 		$1.7M Buy
33,247
+2,808
+9% +$141K ﹤0.01% 1560
2017
Q4 		$1.41M Buy
30,439
+105
+0.3% +$5.15K ﹤0.01% 1652
2017
Q3 		$1.62M Sell
30,334
-530
-2% -$31.4K ﹤0.01% 1528
2017
Q2 		$1.92M Buy
30,864
+2,212
+8% +$133K ﹤0.01% 1468
2017
Q1 		$1.94M Buy
28,652
+4,070
+17% +$310K ﹤0.01% 1424
2016
Q4 		$1.73M Buy
24,582
+30
+0.1% +$2.13K ﹤0.01% 1425
2016
Q3 		$1.74M Buy
24,552
+70
+0.3% +$4.47K ﹤0.01% 1411
2016
Q2 		$1.2M Sell
24,482
-33,260
-58% -$2.15M ﹤0.01% 1521
2016
Q1 		$3.31M Buy
57,742
+557
+1% +$36.4K ﹤0.01% 1246
2015
Q4 		$6.42M Buy
57,185
+247
+0.4% +$24.7K 0.01% 896
2015
Q3 		$5.48M Buy
56,938
+34,370
+152% +$3.94M 0.01% 964
2015
Q2 		$2.31M Buy
22,568
+17,016
+306% +$1.32M ﹤0.01% 1379
2015
Q1 		$345K Buy
5,552
+467
+9% +$25.9K ﹤0.01% 2328
2014
Q4 		$223K Sell
5,085
-279
-5% -$12.8K ﹤0.01% 2569
2014
Q3 		$303K Buy
5,364
+1,090
+26% +$54.8K ﹤0.01% 2332
2014
Q2 		$192K Buy
+4,274
New +$176K ﹤0.01% 2738

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RARE Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Ultragenyx Pharmaceutical (RARE) stake by 15% in Q2 2026, selling an estimated $1.73M and leaving 381,420 shares worth $12.7M. The position accounts for 0.01% of the portfolio, ranked #794.

Manulife (Manufacturers Life Insurance) first reported a position in RARE in Q2 2014 and has held it in 46 quarters since. The position peaked at $14.2M in Q2 2025. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 381,420 shares of Ultragenyx Pharmaceutical worth $12.7M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 69,699 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $1.73M.
  • Ultragenyx Pharmaceutical made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #794 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Ultragenyx Pharmaceutical in Q2 2014 and has held it in 46 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Ultragenyx Pharmaceutical position peaked at $14.2M in Q2 2025.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.